Field evaluation of the performance of seven Antigen Rapid diagnostic tests for the diagnosis of SARs-CoV-2 virus infection in Uganda

Show other versions (1)

<h4>Objective</h4> The objective of this study was to evaluate the performance of seven antigen rapid diagnostic tests (Ag RDTs) in a clinical setting to identify those that could be recommended for use in the diagnosis of SARS-CoV-2 infection in Uganda. <h4>Methods</h4> This...

Full description

Bibliographic Details
Published in:	PLoS ONE
Main Authors:	Josephine Bwogi, Tom Lutalo, Phionah Tushabe, Henry Bukenya, James Peter Eliku, Isaac Ssewanyana, Susan Nabadda, Christopher Nsereko, Matthew Cotten, Robert Downing, Julius Lutwama, Pontiano Kaleebu, EPI Laboratory team, UVRI -COVID 19 Technical team
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-01-01
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089886/?tool=EBI

Similar Items

Field evaluation of the performance of seven Antigen Rapid diagnostic tests for the diagnosis of SARs-CoV-2 virus infection in Uganda.
by: Josephine Bwogi, et al.
Published: (2022-01-01)

Rubella virus genotype 2B endemicity and related utility of serum-based molecular characterization in Uganda
by: Phionah Tushabe, et al.
Published: (2023-09-01)

Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples
by: Aminah Nalumansi, et al.
Published: (2021-03-01)

Sabin polio virus protein 1 (VP1) evolution in patients with acute flaccid paralysis from 2010 to 2016 in Uganda
by: Mary Bridget Nanteza, et al.
Published: (2023-08-01)

Optimisation and Validation of a conventional ELISA and cut-offs for detecting and quantifying anti-SARS-CoV-2 Spike, RBD, and Nucleoprotein IgG, IgM, and IgA antibodies in Uganda
by: Gerald Kevin Oluka, et al.
Published: (2023-03-01)

The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort
by: Jennifer Serwanga, et al.
Published: (2024-05-01)

Sustained spike-specific IgG antibodies following CoronaVac (Sinovac) vaccination in sub-Saharan Africa, but increased breakthrough infections in baseline spike-naive individuals
by: Jackson Sembera, et al.
Published: (2023-11-01)

Investigating the etiology of acute febrile illness: a prospective clinic-based study in Uganda
by: Brian K. Kigozi, et al.
Published: (2023-06-01)

Co-Surveillance of Rotaviruses in Humans and Domestic Animals in Central Uganda Reveals Circulation of Wide Genotype Diversity in the Animals
by: Josephine Bwogi, et al.
Published: (2023-03-01)

Sustained S-IgG and S-IgA antibodies to Moderna’s mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations
by: Jennifer Serwanga, et al.
Published: (2024-01-01)

The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies
by: Violet Ankunda, et al.
Published: (2024-02-01)

Thirteen-Year Sequelae of Marburg Virus Disease Survival: Persistent Cardiometabolic, Immunometabolic, and Haematological Alterations in the Absence of Psychological Morbidity
by: Jennifer Serwanga, et al.
Published: (2025-07-01)

EMERGING VIRUSES ARE AN UNDERESTIMATED CAUSE OF UNDIAGNOSED FEBRILE ILLNESS IN UGANDA
by: S. Ashraf, et al.
Published: (2023-05-01)

Coronavirus Disease-19: Quarantine Framework for Travelers Entering Korea
by: Quarantine Management Team, COVID-19 National Emergency Response Center
Published: (2020-05-01)

Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy
by: Jennifer Serwanga, et al.
Published: (2023-05-01)

Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens
by: Hellen Nantambi, et al.
Published: (2023-04-01)

Case Reports of Human Monkeypox Virus Infections, Uganda, 2024
by: Nicholas Bbosa, et al.
Published: (2025-01-01)

Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles.
by: Jennifer Serwanga, et al.
Published: (2024-01-01)

Evaluation of HIV-1 rapid tests and identification of alternative testing algorithms for use in Uganda
by: Pontiano Kaleebu, et al.
Published: (2018-02-01)

Impact of BCG revaccination on the response to unrelated vaccines in a Ugandan adolescent birth cohort: randomised controlled trial protocol C for the ‘POPulation differences in VACcine responses’ (POPVAC) programme
by: Pontiano Kaleebu, et al.
Published: (2021-02-01)

Severe morbidity and hospital-based mortality from Rift Valley fever disease between November 2017 and March 2020 among humans in Uganda
by: Zacchaeus Anywaine, et al.
Published: (2024-05-01)

Uncovering the viral aetiology of undiagnosed acute febrile illness in Uganda using metagenomic sequencing
by: Shirin Ashraf, et al.
Published: (2025-03-01)

Practical Recommendations of Peking Union Medical College Hospital for Assessment and Management of COVID-19 in Primary Care (2023)
by: Multi-disciplinary Expert Team for Primary Care COVID-19 Practice, Peking Union Medical College Hospital
Published: (2023-01-01)

Widespread human exposure to ledanteviruses in Uganda: A population study.
by: James G Shepherd, et al.
Published: (2024-07-01)

Acquired tracheomalacia due to SARS‐CoV‐2 pneumonia
by: David Espejo, et al.
Published: (2024-01-01)

Coronavirus Disease-19: Summary of 2,370 Contact Investigations of the First 30 Cases in the Republic of Korea
by: COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, et al.
Published: (2020-04-01)

Corrigendum to “Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea” [Osong Public Health Res Perspect 2020;11(2):85–90]
by: COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, et al.
Published: (2020-06-01)

Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea
by: COVID-19 National Emergency Response Center, Epidemiology and Case Management Team, et al.
Published: (2020-04-01)

Possible Interruption of Measles Virus Transmission, Uganda, 2006–2009
by: Frederick N. Baliraine, et al.
Published: (2011-01-01)

Re-testing as a method of implementing external quality assessment program for COVID-19 real time PCR testing in Uganda.
by: Erick Jacob Okek, et al.
Published: (2024-01-01)

Re-testing as a method of implementing external quality assessment program for COVID-19 real time PCR testing in Uganda
by: Erick Jacob Okek, et al.
Published: (2024-01-01)

COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort
by: Billy Nsubuga Mayanja, et al.
Published: (2017-05-01)

Maternal Latent Mycobacterium tuberculosis Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in Uganda
by: Lawrence Lubyayi, et al.
Published: (2020-05-01)

Vaccination against SARS-CoV-2 in a rural Ugandan population
by: Joseph Mugisha, et al.
Published: (2023-12-01)

The detection of 3 ambiguous type 2 vaccine-derived polioviruses (VDPV2s) in Uganda
by: Mary Bridget Nanteza, et al.
Published: (2018-04-01)

SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus
by: Giulia Matusali, et al.
Published: (2021-04-01)

Identification of undetected SARS-CoV-2 infections by clustering of Nucleocapsid antibody trajectories
by: Leslie R. Zwerwer, et al.
Published: (2025-05-01)

Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections
by: Joel Hellewell, et al.
Published: (2021-04-01)

Correction to: Nationwide system to centralize decisions around ECMO use for severe COVID-19 pneumonia in Japan (Special Correspondence)
by: Japan ECMOnet for COVID-19
Published: (2020-05-01)

Challenges and Mitigation Strategies in Providing Family Planning Services during the COVID-19 Pandemic: Health-care Providers’ Perspectives from Rural and Urban Public Health Facilities in Maharashtra, India
by: Deepti Tandon, et al.
Published: (2025-01-01)